Company
Headquarters: Tsuen Wan, Hong Kong
Employees: 33
CEO: Ms. Bik-Kwan Wong
HK$75.2 Million
HKD as of Jan. 1, 2024
US$9.6 Million
Company | Market Cap (USD) |
---|---|
McKesson Corporation | $63.92 B |
Cencora, Inc. | $43.41 B |
Cardinal Health, Inc. | $26.02 B |
Henry Schein, Inc. | $9.72 B |
Sinopharm Group Co. Ltd | $8.04 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and holds trademarks, as well as provides maintenance services. It sells its products to various private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users. The company was founded in 1997 and is based in Tsuen Wan, Hong Kong. Grand Brilliance Group Holdings Limited is a subsidiary of B&A Success Limited.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Grand Brilliance Group Holdings Ltd has the following listings and related stock indices.
Stock: HKEX: 8372 wb_incandescent